Cryoport Expands Logistics Services for Reproductive Medicine with The World Egg Bank

LAKE FOREST, Calif.--(BUSINESS WIRE)-- Cryoport, Inc. (OTCBB: CYRX) continues its momentum as leader in advanced logistics services for reproductive medicine with The World Egg Bank (TWEB) using its advanced technology “turnkey logistics solution.” Through its partnership, TWEB employs Cryoport’s cloud-based logistics management software platform (known as the CryoportalTM) complemented by its patented dry vapor Cryoport Express® Shippers and Cryoport’s logistics expertise. TWEB successfully ships their critical customer products in this manner, both domestically and internationally.

In collaboration with TWEB, Cryoport customized its complete data monitoring to TWEB’s specific requirements as well as the use of TWEB’s custom shipping goblet within the Cryoport Express® Shipper. Thus, fully documented “chain-of-custody” and “chain-of-condition” is achieved. This extra care helps ensure the quality, safety, and stability of the shipped specimens.

“Our customers insist on reliability; they rely on us to ensure state of the art technologies for cryopreservation and transportation,” said Diana Thomas, the CEO and Founder of TWEB. “Choosing Cryoport was easy as its services are unique and based on the most advanced technologies. The right global logistics partner is key to our success. Cryoport, with its customer-centric approach to handling our products, has proven that it can reliably maintain and accurately document cryogenic chain of condition for temperatures during shipping. This is critical for specimen integrity and ultimately a successful IVF treatment. Cryoport’s services and patented technologies have now become an integral part of our solutions, both for domestic and international shipments.”

“We are very pleased that The World Egg Bank is using our turnkey logistics solutions for all its shipments of human eggs,” stated Cryoport President and CEO Jerrell Shelton. “Reproductive medicine is important and a fast growing business segment for Cryoport. It requires some of the highest standards in cold chain logistics. Monitoring these cryopreserved specimens for chain-of-condition and chain-of-custody provides our clients with the data for the surety of quality. We are proud of our advanced technology-centric cold chain solutions. We are the only company that provides economic, reliable, effective transportation of reproductive specimens to their intended destinations at constant cryogenic temperatures in a safe, speedy manner.”

About Cryoport, Inc.

Cryoport provides leading edge frozen shipping logistics solutions to the biotechnology and life science industries through the combination of purpose built proprietary hardware and software technologies and skilled total turnkey management of the entire logistics process. Cryoport Express® liquid nitrogen dry vapor shippers are validated to maintain a constant -150°C temperature for a 10 plus day dynamic shipment duration, and its Cryoportal™ Logistics Management Platform manages the entire shipment process, including initial order input, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport’s total turnkey logistics solutions offer reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides a “green” and environmentally friendly solution. Cryoport service options include recording the “chain of condition” and “chain of custody” for all shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes. For more information visit

About The World Egg Bank

The World Egg Bank provides fertility services to women in need of donated eggs to achieve pregnancy. The company is operating the leading match-making service in the US and internationally, bringing donors and recipients together to exchange fresh human eggs. In 2004, it provided the first commercial frozen human eggs in the world. Then in 2005, the first child conceived of a frozen egg in the US was born under the care of the founders. The World Egg Bank scientific team includes the three doctors that perfected the technology and protocols for cryogenically freezing and thawing human eggs.

Forward Looking Statements

Statements in this press release which are not purely historical, including statements regarding Cryoport, Inc.’s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, and technical development risks. The company’s business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended March 31, 2013. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Cryoport, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

Cryoport, Inc.
Robert Stefanovich

Source: Cryoport, Inc.